Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-01-01 @ 6:42 PM
Study NCT ID:
NCT00816803
Status:
COMPLETED
Last Update Posted:
2009-01-05
First Post:
2008-12-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cell Transplant in Spinal Cord Injury Patients
Sponsor:
Cairo University
Organization:
Study Overview
Official Title:
Autologous Bone Marrow Derived Cell Transplant in Spinal Cord Injury Patients
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to assess the safety of autologous bone marrow derived cell transplant in chronic spinal cord injury patients. The hypothesis is that the availability of bone marrow derived mesenchymal stem cells at the sites of injury promote neuronal regeneration.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: